Works Cited

1. Colberg S. Diabetes Free Kids: A Take Charge Plan for Preventing and Treating Type 2 Diabetes in Children. New York, NY: Avery; 2005.

2. Kaufman FR. Diabesity: The Obesity-Diabetes Epidemic That Threatens America and What We Must Do to Stop It. New York, NY: Bantam; 2005.

3. World Health Organization. Controlling the Global Obesity Epidemic. Available athttps://www.who.int/nutrition/topics/obesity/en. Last accessed September 22, 2020.

4. Lightwood J, Bibbins-Domingo K, Coxson P, Wang YC, Williams L, Goldman L. Forecasting the future economic burden of current adolescent overweight: an estimate of the coronary heart disease policy model. Am J Public Health. 2009;99(12):2230-2237.

5. Centers for Disease Control and Prevention. Obesity prevalence among low-income, preschool-aged children: United States, 1998–2008. MMWR. 2009;58(28):769-796.

6. Alemzadeh R, Rising R, Lifshitz F. Obesity in children. In: Lifshitz F (ed). Pediatric Endocrinology Volume 1: Obesity, Diabetes Mellitus, Insulin Resistance, and Hypoglycemia. 5th ed. New York, NY: Informa; 2007: 1-36.

7. World Health Organization. Obesity and Overweight: Key Facts. Available at https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight. Last accessed September 22, 2020.

8. Venes D (ed). Taber's Cyclopedic Medical Dictionary. 23rd ed. Philadelphia, PA: F.A. Davis Co.; 2017.

9. National Center for Health Statistics. Prevalence of Overweight, Obesity, and Extreme Obesity Among Adults: United States, Trends 1960–1962 Through 2013–2014. Available at https://www.cdc.gov/nchs/data/hestat/obesity_adult_13_14/obesity_adult_13_14.pdf. Last accessed September 22, 2020.

10. Hales CM, Carroll MD, Fryar CD, Ogden CL. Prevalence of obesity and severe obesity among adults: United States, 2017–2018. NCHS Data Brief. 2020;360:1-7.

11. World Obesity Federation. Obesity: Missing the 2025 Global Targets. Available at https://data.worldobesity.org/publications/WOF-Missing-the-2025-Global-Targets-Report-FINAL-WEB.pdf. Last accessed September 22, 2020.

12. Daniels SR, Arnett DK, Eckel RH, et al. AHA scientific statement: overweight in children and adolescents: pathophysiology, consequences, prevention, and treatment. Circulation. 2005;111:1999-2012.

13. Centers for Disease Control and Prevention. About the National Health and Nutrition Examination Survey. Available at https://www.cdc.gov/nchs/nhanes/about_nhanes.htm. Last accessed October 14, 2020.

14. Bishop J, Middendorf R, Babin T, Tilson W. ASPE Research Brief: Childhood Obesity. Available at https://aspe.hhs.gov/basic-report/aspe-childhood-obesity-white-paper. Last accessed September 22, 2020.

15. Ogden CL, Carroll MD, Curtin LR, McDowell MA, Tabak CJ, Flegal KM. Prevalence of high body mass index in U.S. children and adolescents, 2007–2008. JAMA. 2010;303(3):242-249.

16. Ogden CL, Carroll MD, Lawman KG, et al. Trends in obesity prevalence among children and adolescents, United States, 1998–1994 through 2013–2014. JAMA. 2016;315(21):2292-2299.

17. Michalsky M, Reichard K, Inge T, Pratt J, Lenders C; American Society for Metabolic and Bariatric Surgery. ASMBS pediatric committee best practice guidelines. Surg Obes Relat Dis. 2012;8(1):1-7.

18. Cawley J. The economics of childhood obesity. Health Aff (Millwood). 2010;29(3):364-371.

19. Trasande L, Chatterjee S. The impact of obesity on health service utilization and costs in childhood. Obesity (Silver Spring). 2009;17(9):1749-1754.

20. Bibbins-Domingo K, Coxson P, Pletcher MJ, Lightwood J, Goldman L. Adolescent overweight and future adult coronary heart disease. N Engl J Med. 2007;357(23):2371-2379.

21. Ludwig DS, Pollack HA. Obesity and the economy: from crisis to opportunity. JAMA. 2009;301(5):533-535.

22. Bhattacharya B, Bundorf MK. The incidence of the healthcare costs of obesity. J Health Econ. 2009;28(3):649-658.

23. Dall TM, Zhang Y, Chen YJ, Quick WW, Yangh WG, Fogli J. The economic burden of diabetes. Health Aff (Millwood). 2010;29(2):297-303.

24. Sherry B, Blanck HM, Galuska DA, Pan L, Dietz WH. Vital signs: state-specific obesity prevalence among adults—United States, 2009. MMWR. 2010;59:1-5.

25. Hammond RA, Levine R. The economic impact of obesity in the United States. Diabetes Metab Syndr Obes. 2010;3:285-295.

26. Finkelstein EA, Graham WC, Malhotra R. Lifetime direct medical costs of childhood obesity. Pediatrics. 2014;133(5):854-862.

27. American Diabetes Association. Statistics About Diabetes. Available at https://www.diabetes.org/resources/statistics/statistics-about-diabetes?loc=db-slabnav. Last accessed October 9, 2020.

28. Lytle LA. Examining the etiology of childhood obesity: the IDEA study. Am J Community Psychol. 2009;44(3-4):338.

29. Huang TT, Glass TA. Transforming research strategies for understanding and preventing obesity. JAMA. 2008;300(15):1811-1813.

30. Budd GM, Hayman LL. Addressing the childhood obesity crisis: a call to action. MCN Am J Matern Child Nurs. 2008;33(2):111-118.

31. Daniels SR, Jacobson MS, McCrindle BW, Eckel RH, McHugh-Sanner B. American Heart Association Childhood Obesity Research Summit Report. Circulation. 2009;119(15):e489-e517.

32. Centers for Disease Control and Prevention. Overweight and Obesity: A Growing Problem. Available at https://www.cdc.gov/obesity/childhood/causes.html. Last accessed September 22, 2020.

33. Mayo Clinic. Metabolism and Weight Loss: How You Burn Calories. Available at https://www.mayoclinic.org/healthy-lifestyle/weight-loss/in-depth/art-20046508. Last accessed September 24, 2020.

34. Esparza J, Fox C, Harper IT, et al. Daily energy expenditure in Mexican and USA Pima Indians: low physical activity as a possible cause of obesity. Int J Obes Relat Metab Disord. 2000;24(1):55-59.

35. Stephenson J. Severe childhood obesity. JAMA. 2010;303(3):215.

36. Centers for Disease Control and Prevention. Childhood Obesity Facts. Available at https://www.cdc.gov/obesity/data/childhood.html. Last accessed September 28, 2020.

37. Freedman DS, Mei Z, Srinivasan SR, et al. Cardiovascular risk factors and excess adiposity among overweight children and adolescents: the Bogalusa Heart Study. J Ped. 2007;150(1):12-17.

38. Centrella-Nigro A. Hispanic children and overweight: causes and interventions. Pediatr Nurs. 2009;35(6):352-356.

39. Shepherd A. Obesity prevalence, causes and clinical consequences. Nurs Stand. 2009;23(52):51-57.

40. Thomas B, Bishop J. Obesity: Manual of Dietetic Practice. 4th ed. Oxford: Blackwell; 2007.

41. Troke RC, Tan TM, Bloom SR. The future role of gut hormones in the treatment of obesity. Ther Adv Chronic Dis. 2014;5(1):4-14.

42. Druce M, Wren A, Park A, Milton, et al. Ghrelin increases food intake in obese as well as lean subjects. Int J Obes (Lond). 2005;29:1130-1136.

43. Schellekens H, Dinan T, Cryan J. Lean mean fat reducing "ghrelin" machine: hypothalamic ghrelin and ghrelin receptors as therapeutic targets in obesity. Neuropharmacology. 2010;58:2-16.

44. Ben-Sefer E, Ben-Natan M, Ehrenfeld M. Childhood obesity: current literature, policy and implications for practice. Int Nurs Rev. 2009;56(2):166-173.

45. Kann L, McManus T, Harris WA, et al. Youth Risk Behavior Surveillance—United States, 2017. MMWR. 2018;67(8):1-479.

46. Centers for Disease Control and Prevention. The Obesity Epidemic and United States Students. Available at https://www.cdc.gov/healthyyouth/data/yrbs/pdf/2015/2015_us_obesity.pdf. Last accessed September 29, 2020.

47. Alliance for a Healthier Generation. About Childhood Obesity: Get Informed. https://www.healthiergeneration.org/about-us/our-cause. Last accessed September 29, 2020.

48. Centers for Disease Control and Prevention. Growth Charts. Available at https://www.cdc.gov/growthcharts. Last accessed September 29, 2020.

49. Centers for Disease Control and Prevention. About Child and Teen BMI. Available at https://www.cdc.gov/healthyweight/assessing/bmi/childrens_bmi/about_childrens_bmi.html. Last accessed September 29, 2020.

50. Centers for Disease Control and Prevention. Ten-State Nutrition Survey, 1968–1970. Atlanta, GA: Centers for Disease Control and Prevention; 1972.

51. Centers for Disease Control and Prevention. Nutrition Surveillance: Annual Summary, 1982. Atlanta, GA: Centers for Disease Control and Prevention; 1984.

52. Centers for Disease Control and Prevention. Overweight and Obesity: Surveillance Systems. Available at https://www.cdc.gov/obesity/data/surveillance.html. Last accessed October 5, 2020.

53. Pan L, Blanck HM, Park S, et al. State-specific prevalence of obesity among children aged 2–4 years enrolled in the Special Supplemental Nutrition Program for Women, Infants, and Children—United States, 2010–2016. MMWR. 2019;68:1057–1061.

54. Fryar CD, Carroll MD, Ogden CL. Prevalence of Overweight and Obesity Among Children and Adolescents: United States, 1963–1965 through 2011–2012. Atlanta, GA: National Center for Health Statistics; 2014.

55. Kipping RR, Jago R, Lawlor DA. Obesity in children. Part 1: epidemiology, measurement, risk factors, and screening. BMJ. 2008;337:a1824.

56. Poirier P, Giles TD, Bray GA, et al. Obesity and cardiovascular disease: pathophysiology, evaluation, and effect of weight loss: an update of the 1997 American Heart Association Scientific Statement on Obesity and Heart Disease from the Obesity Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation. 2006;113(6):898-918.

57. Inge T, Xanthakos S. Obesity at the extremes: the eyes only see what the mind is prepared to comprehend. J Pediatr. 2010;157(1): 3-4.

58. Jung UJ, Choi MS. Obesity and its metabolic complications: the role of adipokines and the relationship between obesity, inflammation, insulin resistance, dyslipidemia and nonalcoholic fatty liver disease. Int J Mol Sci. 2014;15(4):6184-6223.

59. Centers for Disease Control and Prevention. Summary Health Statistics: National Health Interview Survey, 2018, Table A15. Available at https://ftp.cdc.gov/pub/Health_Statistics/NCHS/NHIS/SHS/2018_SHS_Table_A-15.pdf. Last accessed September 22, 2020.

60. Lee HS, Park HK, Hwang JS. HbA1c and glucose intolerance in obese children and adolescents. Diabet Med. 2012;29(7):e102-e105.

61. Franks PW, Hanson RL, Knowler WC, Sievers ML, Bennett PH, Looker HC. Childhood obesity, other cardiovascular risk factors, and premature death. N Engl J Med. 2010;362(6):485-493.

62. Morales Pozzo AE. Pediatric Type 2 Diabetes Mellitus. Available at https://reference.medscape.com/article/925700-overview. Last accessed October 9, 2020.

63. Pinhas-Hamiel O, Dolan LM, Daniels SR, Standiford D, Khoury PR, Zeitler P. Increased incidence of non-insulin-dependent diabetes mellitus among adolescents. J Pediatr. 1996;128(5 Pt 1):608-615.

64. McClean KM, Kee F, Young IS, Elborn JS. Obesity and the lung: 1. Epidemiology. Thorax. 2008;63(7):649-654.

65. Mallory GB, Fiser DH, Jackson R. Sleep-associated breathing disorders in morbidly obese children and adolescents. J Pediatr. 1989;115(6):892-897.

66. Narang I, Mathew JL. Childhood obesity and obstructive sleep apnea. J Nutr Metabol. 2012;134202.

67. Papoutsakis C, Priftis KN, Drakouli M, et al. Childhood overweight/obesity and asthma: is there a link? A systematic review of recent epidemiologic evidence. J Acad Nutr Diet. 2013;113(1):77-105.

68. Partnership for America's Economic Success. Issue Brief 3. Early Childhood Health Problems and Prevention Strategies: Costs and Benefits. Available at https://silo.tips/download/early-childhood-health-problems-and-prevention-strategies-costs-and-benefits. Last accessed October 12, 2020.

69. Lifshitz F. Obesity in children. J Clin Res Pediatr Endocrinol. 2008;1(2):53-60.

70. Helmrath MA, Brandt ML, Inge TH. Adolescent obesity and bariatric surgery. Surg Clin N Am. 2006;86(2):441-454.

71. Stevenson SB. Pseudotumor cerebri: yet another reason to fight obesity. J Pediatr Health Care. 2008;22(1):40-43.

72. Sanyal AJ, Campbell-Sargent C, Mirshahi F, et al. Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities. Gastroenterology. 2001;120(5):1183-1192.

73. Ergun-Longmire B, Maclaren NK. Insulin resistance syndrome in childhood and beyond. In: Lifshitz F (ed). Pediatric Endocrinology Volume 1: Obesity, Diabetes Mellitus, Insulin Resistance, and Hypoglycemia. 5th ed. New York, NY: Informa; 2007: 211-249.

74. Nobili V, Pinzani M. Pediatric non-alcoholic fatty liver disease. Gut. 2010;59(5):561-564.

75. Clark JM, Brancati FL, Diehl AM. The prevalence and etiology of elevated aminotransferase levels in the United States. Am J Gastroenterol. 2003;98(5):960-967.

76. Falakaflaki B, Mazloomzadeh S, Moradzade A. Comparison of renal function between normal-weight and overweight children. Indian J Nephrol. 2012;22(3):193-195.

77. Wang Y, Chen X, Klag MJ, Caballero B. Epidemic of childhood obesity: implications for kidney disease. Adv Chronic Kidney Dis. 2006;13(4):336-351.

78. McGovern L, Johnson JN, Paulo R, et al. Clinical review: treatment of pediatric obesity: a systemic review and meta-analysis of randomized trials. J Clin Endocrinol Metab. 2008;93(12):4600-4605.

79. Baur LA. Tackling the epidemic of childhood obesity. CMAJ. 2009;180(7):701-702.

80. LexiComp Online. Available at https://online.lexi.com. Last accessed October 12, 2020.

81. Botero D, Lifshitz F. Treatment of pediatric obesity. In: Lifshitz F (ed). Pediatric Endocrinology Volume 1: Obesity, Diabetes Mellitus, Insulin Resistance, and Hypoglycemia. 5th ed. New York, NY: Informa; 2007: 37-56.

82. U.S. Food and Drug Administration. Drug Approval Package: Belviq (Lorcaserin Hydrochloride) Tablets. Available at https:// www.accessdata.fda.gov/drugsatfda_docs/nda/2012/022529Orig1s000TOC.cfm. Last accessed October 12, 2020.

83. Inge TH, Krebs NF, Garcia VF, et al. Bariatric surgery for severely overweight adolescents: concerns and recommendations. Pediatrics. 2004;114(1):217-223.

84. Brandt ML, Harmon CM, Helmrath MA, Inge TH, McKay SV, Michalsky MP. Morbid obesity in pediatric diabetes mellitus: surgical options and outcomes. Nat Rev Endocrinol. 2010;6(11):637-645.

85. Hsia DS, Fallon SC, Brandt ML. Adolescent bariatric surgery. Arch Pediatr Adolesc Med. 2012;166(8):757-766.

86. Endocrine Today. Bariatric Surgery in Children and Adolescents: Procedures on the Rise. Available at https://www.healio.com/news/endocrinology/20120325/bariatric-surgery-in-children-and-adolescents-procedures-on-the-rise. Last accessed October 14, 2020.

87. Iannelli A, Dainese R, Piche T, Facchiano E, Gugenheim J. Laparoscopic sleeve gastrectomy for morbid obesity. World J Gastroenterol. 2008;14(6):821-827.

88. Sugarman HJ, DeMaria EJ, Kellum JM, et al. Bariatric surgery for severely obese adolescents. J Gastrointest Surg. 2003;7(1):102-108.

89. Pratt JSA, Lenders CM, Dionne EA, et al. Best practice update for pediatric/adolescent weight loss surgery. Obesity. 2009;17(5): 901-910.

90. Frank P, Crookes PF. Short- and long-term surgical follow-up of the postbariatric surgery patient. Gastroenterol Clin North Am. 2010;39(1):135-146.

91. Zeller MH, Modi AC, Noll JG, Long JD, Inge TH. Psychosocial functioning improves following adolescent bariatric surgery. Obesity. 2009;17(5):985-990.

92. Treadwell JR, Sun F, Schoelles K. Systematic review and meta-analysis of bariatric surgery for pediatric obesity. Ann Surg. 2008;248(5):763-776.

93. Holterman AX, Browne A, Tussing L, et al. A prospective trial for laparoscopic adjustable gastric banding in morbidly obese adolescents: an interim report of weight loss, metabolic and quality of life outcomes. J Pediatr Surg. 2010;45(1):74-79.

94. Inge TH, Miyano G, Bean J, et al. Reversal of type 2 diabetes mellitus and improvements in cardiovascular risk factors after surgical weight loss in adolescents. Pediatrics. 2009;123(1):214-222.

95. Zitsman JL, Digiorgi MF, Marr JR, Witt MA, Bessler M. Comparative outcomes of laparoscopic adjustable gastric banding in adolescents and adults. Surg Obes Relat Dis. 2011;7(6):720-726.

96. Edwards ED, Jacob BP, Gagner M, Pomp A. Presentation and management of common post-weight loss surgery problems in the emergency department. Ann Emerg Med. 2006;47(2):160-166.

97. Maggard MA, Shugarman LR, Suttorp M, et al. Meta-analysis: surgical treatment of obesity. Ann Intern Med. 2005;142(7):547-559.

98. Mechanick JI, Kushner RF, Sugarman HJ, et al. American Association of Clinical Endocrinologists, The Obesity Society, and American Society for Metabolic and Bariatric Surgery medical guidelines for clinical practice for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient. Surg Obes Rel Dis. 2008;4(5 suppl):S109-S184.

99. Ethicon Endo-Surgery, Inc. Instructions for Use: REALIZE Adjustable Gastric Band. Cincinnati, OH: Ethicon Endo-Surgery, Inc.; 2007.

100. U.S. Food and Drug Administration. LAP-BAND Adjustable Gastric Banding (LAGB) System: P000008. Available at https:// www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpma/pma_template.cfm?id=p000008. Last accessed October 14, 2020.

101. An J, Hayman LI, Park Y, Dudaj TK, Ayres CG. Web-based weight management programs for children and adolescents: a systemic review of randomized control trial studies. ANS Adv Nurs Sci. 2009;32(2):222-240.

102. Lavizzo-Mourey R. Childhood obesity: what it means for physicians. JAMA. 2007;298(8):920-922.

103. Centers for Disease Control and Prevention. Overweight and Obesity: State and Community Programs. Available at https://www.cdc.gov/nccdphp/dnpao/state-local-programs/index.html. Last accessed October 14, 2020.

104. Kanda P. Prevention of pediatric overweight and obesity. Pediatrics. 2003;112(2):424-430.

105. Bruner C. From child health coverage to healthy child development: federal health reform opportunities to improve the health of America's youngest children. J Pediatr. 2010;157(1):1-2.

106. National Football League. NFL Play 60. Available at https://www.nfl.com/causes/play60. Last accessed October 14, 2020.

107. Centers for Disease Control and Prevention. Summary Health Statistics for U.S. Adults: National Health Interview Survey, 2012. Available at https://www.cdc.gov/nchs/data/series/sr_10/sr10_260.pdf. Last accessed September 22, 2020.

108. Zwintscher NP, Azarow KS, Horton JD, Newton CR, Martin MJ. The increasing incidence of adolescent bariatric surgery. J Pediatr Surg. 2013;48(12):2401-2407.

109. World Health Organization. Global Strategy on Diet, Physical Activity and Health: Global Strategy: Overall Goal. Available at https://www.who.int/dietphysicalactivity/goals/en. Last accessed October 14, 2020.

110. U.S. Food and Drug Administration. FDA Approves Weight-Management Drug Contrave. Available at https://wayback.archive-it.org/7993/20170112222826/http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm413896.htm. Last accessed October 12, 2020.

111. U.S. Food and Drug Administration. FDA Approves Weight-Management Drug Saxenda. Available at https://wayback.archive-it.org/7993/20170111160832/http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm427913.htm. Last accessed October 12, 2020.

112. State of Childhood Obesity, Robert Wood Johnson Foundation. Obesity Rates and Trend Data. Available at https://stateofchildhoodobesity.org/data. Last accessed September 22, 2020.

113. Organisation for Economic Co-operation and Development. Obesity Update 2017. Available at http://www.oecd.org/health/obesity-update.htm. Last accessed September 22, 2020.

114. State of Childhood Obesity, Robert Wood Johnson Foundation. Obesity Rates for Youth Ages 10 to 17. Available at https://stateofobesity.org/children1017. Last accessed September 22, 2020.

115. Finkelstein EA, Trogdon JG, Cohen JW, Dietz W. Annual medical spending attributable to obesity: payer-and service-specific estimates. Health Aff (Millwood). 2009;28(5):w822-w831.

116. Wier LM, Encinosa W. Statistical Brief #138: Obesity in Children: Hospitalizations from 2000 to 2009. Available at https://www.hcup-us.ahrq.gov/reports/statbriefs/sb138.jsp. Last accessed September 22, 2020.

117. Kim DD, Basu A. Estimating the medical care costs of obesity in the United States: systematic review, meta-analysis, and empirical analysis. Val Health. 2016;19(5):602-613.

118. Sonntag D. Why early prevention of childhood obesity is more than a medical concern: a health economic approach. Ann Nutr Metab. 2017;70:175-178.

119. Andes LJ, Cheng YJ, Rolka DB, Gregg EW, Imperatore G. Prevalence of prediabetes among adolescents and young adults in the United States, 2005–2016. JAMA Pediatr. 2020;174(2):e194498.

120. Woodard K, Louque L, Hsia DS. Medications for the treatment of obesity in adolescents. Ther Adv Endocrinol Metab. 2020;11:1-12.

121. Pratt JSA, Brown A, Brown NT, et al. American Society for Metabolic and Bariatric Surgery: ASMBS pediatric metabolic and bariatric surgery guidelines, 2018. Surg Obes Relat Dis. 2018;14:882-901.

122. Armstrong SC. AAP Guidance Calls for Better Access to Bariatric Surgery for Teens with Severe Obesity. Available at https:// www.aappublications.org/news/aapnewsmag/2019/10/27/bariatricsurgery102719.full.pdf. Last accessed October 14, 2020.

123. U.S. Food and Drug Administration. FDA Requests the Withdrawal of the Weight-Loss Drug Belviq, Belviq XR (Lorcaserin) From the Market. Available at https://www.fda.gov/drugs/drug-safety-and-availability/fda-requests-withdrawal-weight-loss-drug-belviq-belviq-xr-lorcaserin-market. Last accessed October 27, 2020.

Evidence-Based Practice Recommendations Citations

1. Registered Nurses' Association of Ontario. Primary Prevention of Childhood Obesity. 2nd ed. Toronto: Registered Nurses' Association of Ontario; 2014. Available at https://rnao.ca/sites/rnao-ca/files/Childhood_obesity_FINAL_19.12.2014.pdf. Last accessed November 10, 2020.

2. Academy of Nutrition and Dietetics. Pediatric Weight Management Evidence-Based Nutrition Practice Guideline. Chicago, IL: Academy of Nutrition and Dietetics; 2015. Available at https://www.andeal.org/topic.cfm?menu=5296&cat=5632. Last accessed November 10, 2020.

3. Styne DM, Arslanian SA, Connor EL, et al. Pediatric obesity—assessment, treatment, and prevention: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2017;102(3):709-757. Available at https://academic.oup.com/jcem/article/102/3/709/2965084. Last accessed November 10, 2020.


Copyright © 2020 NetCE, P.O. Box 997571, Sacramento, CA 95899-7571
Mention of commercial products does not indicate endorsement.